1. Home
  2. VRNA vs CABO Comparison

VRNA vs CABO Comparison

Compare VRNA & CABO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VRNA
  • CABO
  • Stock Information
  • Founded
  • VRNA 2005
  • CABO 1980
  • Country
  • VRNA United Kingdom
  • CABO United States
  • Employees
  • VRNA N/A
  • CABO N/A
  • Industry
  • VRNA Biotechnology: Pharmaceutical Preparations
  • CABO Cable & Other Pay Television Services
  • Sector
  • VRNA Health Care
  • CABO Telecommunications
  • Exchange
  • VRNA Nasdaq
  • CABO Nasdaq
  • Market Cap
  • VRNA 2.2B
  • CABO 2.0B
  • IPO Year
  • VRNA 2017
  • CABO N/A
  • Fundamental
  • Price
  • VRNA $35.66
  • CABO $397.86
  • Analyst Decision
  • VRNA Strong Buy
  • CABO Hold
  • Analyst Count
  • VRNA 6
  • CABO 5
  • Target Price
  • VRNA $43.83
  • CABO $554.40
  • AVG Volume (30 Days)
  • VRNA 1.1M
  • CABO 96.5K
  • Earning Date
  • VRNA 11-04-2024
  • CABO 11-07-2024
  • Dividend Yield
  • VRNA N/A
  • CABO 2.97%
  • EPS Growth
  • VRNA N/A
  • CABO 847.26
  • EPS
  • VRNA N/A
  • CABO 38.05
  • Revenue
  • VRNA $5,624,000.00
  • CABO $1,604,144,000.00
  • Revenue This Year
  • VRNA N/A
  • CABO N/A
  • Revenue Next Year
  • VRNA $554.09
  • CABO N/A
  • P/E Ratio
  • VRNA N/A
  • CABO $10.45
  • Revenue Growth
  • VRNA 1127.95
  • CABO N/A
  • 52 Week Low
  • VRNA $11.39
  • CABO $311.28
  • 52 Week High
  • VRNA $40.13
  • CABO $574.76
  • Technical
  • Relative Strength Index (RSI)
  • VRNA 51.76
  • CABO 59.96
  • Support Level
  • VRNA $36.49
  • CABO $397.84
  • Resistance Level
  • VRNA $40.13
  • CABO $417.23
  • Average True Range (ATR)
  • VRNA 2.01
  • CABO 16.29
  • MACD
  • VRNA -0.30
  • CABO 3.77
  • Stochastic Oscillator
  • VRNA 47.60
  • CABO 75.92

About VRNA Verona Pharma plc

Verona Pharma PLC is a clinical-stage biopharmaceutical company focused on developing and commercializing therapeutics for the treatment of respiratory diseases with unmet medical needs. The company is currently focusing on developing its Ensifentrine product candidate, which will treat chronic obstructive pulmonary disease (COPD), cystic fibrosis (CF), and other respiratory diseases, including asthma.

About CABO Cable One Inc.

Cable One Inc is a telecommunications company. It derives revenue from the provision of broadband, voice, and video services to residential and business customers. From a product perspective, the majority of revenue is sourced from data and video services. This revenue is subscription-based and billed monthly. The company also offers Sparklight TV, an internet protocol-based (IPTV) video service that allows customers with Sparklight TV app to stream video channels from the cloud. The company also derives advertising revenue from selling airtime on its video channels. Voice services are offered over Internet protocols. The company owns a telecommunications infrastructure.

Share on Social Networks: